SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ENSG00000115415.14 | signal transducer and activator of transcription 1 | |
ENSG00000168610.10 | signal transducer and activator of transcription 3 | |
ENSG00000113916.13 | BCL6 transcription repressor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BCL6 | hg19_v2_chr3_-_187454281_187454357 | -0.91 | 2.0e-08 | Click! |
STAT3 | hg19_v2_chr17_-_40540586_40540600 | 0.62 | 3.6e-03 | Click! |
STAT1 | hg19_v2_chr2_-_191878874_191878976 | 0.57 | 8.6e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 33.4 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.4 | 19.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 17.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
5.6 | 16.8 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
1.6 | 10.9 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
2.7 | 10.7 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 10.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.6 | 8.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 8.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.8 | 6.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 33.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 30.1 | GO:0072562 | blood microparticle(GO:0072562) |
1.6 | 22.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 10.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 9.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 8.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 6.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 6.4 | GO:0043194 | axon initial segment(GO:0043194) |
1.5 | 6.1 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 5.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 33.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 19.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.6 | 11.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.7 | 11.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 10.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 8.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 8.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 6.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 5.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 5.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 29.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 22.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 22.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 11.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 8.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 8.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 6.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 6.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 6.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 31.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 21.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 17.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 10.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 8.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.5 | 8.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 7.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 6.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 6.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 5.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |